1) CXCL10 Genes
CXCL10基因
2) Chemokine CXCL10 (IP-10)
趋化因子CXCL10(IP-10)
3) CXCL10-loop3-EGF fusion protein
CXCL10-loop3-EGF融合蛋白
1.
AIM:To evaluate the implication of CXCL10-loop3-EGF fusion protein for the activities of targeting tumor and anti-angiopoiesis.
方法:运用RT-PCR从经IFN-γ刺激活化的PBMC中扩增人CXCL10基因,运用重叠延伸PCR法扩增CXCL10-loop3-EGF融合基因,并将其与载体pTG19-T连接、转化大肠杆菌DH5α、筛选阳性克隆,CXCL10-loop3-EGF融合基因与载体pET32a(+)连接、转化大肠杆菌Origami B(DE3),诱导可溶性表达重组his-CXCL10-loop3-EGF融合蛋白,并经镍柱亲和层析、酶切、超滤及透析等方法获得纯化的重组CXCL10-loop3-EGF融合蛋白。
4) gene
[英][dʒi:n] [美][dʒin]
基因
1.
Study of the Preparation and the Characteristics of pRc/CMV-BChE Gene-chitosan nanoparticles ①;
丁酰胆碱酯酶基因-壳聚糖纳米粒初步研究
2.
Correlation between traditional Chinese medicine syndromes in primary immunoglobulin A nephropathy and A267G in 5'-untranslated region within exonal of megsin gene;
Megsin基因E1-5’UTR区A267G与免疫球蛋白A型肾病阴虚证的相关性
3.
Study on gene chip of leiomyoma of uterus;
子宫肌瘤基因芯片的研究
5) Genes
基因
1.
Study on Apoptosis of Human Leukemia Cells and Its Related Genes Regulation Induced by ~(235) U;
浓缩铀诱发细胞凋亡的形态及基因调控
2.
Screening of lymphatic metastasis-associated genes in esophageal squamous cell carcinoma;
食管癌淋巴结转移相关基因筛选的研究
3.
Study on the Genotyping of Aminoglycoside Modifying Enzymes Genes from Pan-drug Resistant Acinetobacter Baumannii.;
泛耐药鲍曼不动杆菌氨基糖苷类修饰酶基因研究
6) Polymorphism
[英][,pɔli'mɔ:fizəm] [美][,pɑlɪ'mɔrfɪzṃ]
基因
1.
The Study on Apolipoprotein E Gene Polymorphism Characteristics of Cerebral Infarction and Intracerebral Hemorrhage;
脑梗死与脑出血apoE-基因多态性特点研究
2.
The Relations of Gene Polymorphisms of eNOS and FⅦ with Coronary Heart Disease in Henan Han Population;
河南汉族人群一氧化氮合酶和凝血因子Ⅶ基因多态性与冠心病相关性分析
3.
Methods:Polymorphism of the 677th site C/T of MTHFR gene and the 66th site A/G of MTRR gene were detected by polymerase chain reaction-restrction fragment length polymorphism in disease group(n=64) and normal controls(n=104).
目的:研究同型半胱氨酸相关酶中亚甲基四氢叶酸还原酶(MTHFR)及蛋氨酸合成酶还原酶(MTRR)基因的多态性与先天神经管缺陷的关系。
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条